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DOI 10.1016/j.ccr.2011.08.016SUMMARYWnt/b-catenin signaling is essential for stem cell regulation and tumorigenesis, but its molecular mecha-
nisms are not fully understood. Here, we report that FoxM1 is a downstream component of Wnt signaling
and is critical for b-catenin transcriptional function in tumor cells. Wnt3a increases the level and nuclear
translocation of FoxM1, which binds directly to b-catenin and enhances b-catenin nuclear localization and
transcriptional activity. Genetic deletion of FoxM1 in immortalized neural stem cells abolishes b-catenin
nuclear localization. FoxM1mutations that disrupt the FoxM1–b-catenin interaction or FoxM1 nuclear import
prevent b-catenin nuclear accumulation in tumor cells. FoxM1–b-catenin interaction controls Wnt target
gene expression, is required for glioma formation, and represents a mechanism for canonical Wnt signaling
during tumorigenesis.INTRODUCTION
The canonical Wnt signal transduction pathway is a primary
signaling system in stem/progenitor cells and cancer cells
(Clevers, 2006; Huang and He, 2008; Moon et al., 2004; Nusse,
2008). Wnt binding to cell surface receptors, including a Frizzled
(Fz) protein and LDL receptor-related protein 6 (LRP6), initiates
a transduction cascade leading to stabilization of the transcrip-
tion coactivator b-catenin, which then enters the nucleus to
form a transcriptional complex with T cell factor (TCF) or
lymphoid enhancer factor (LEF) to activate the expression ofSignificance
The Wnt/b-catenin signaling pathway is aberrantly activated i
feature of Wnt signaling activation is b-catenin nuclear localiza
elusive. Here we show that FoxM1, which is also activated in m
and plays an essential role in regulating b-catenin activation. F
sufficient for its nuclear localization and transcriptional activa
a mechanism for controlling canonical Wnt signaling and is req
into carcinogenesis and strategies for therapeutic intervention
CWnt target genes, such as c-Myc and cyclin D1 (Clevers, 2006;
Moon et al., 2004). However, the molecular mechanisms that
regulate b-catenin nuclear localization and transcriptional acti-
vation are not well understood.
Wnt/b-catenin signaling plays a critical role in cancer forma-
tion, including regulation of transformation, cell proliferation,
and invasion. Persistent activation of b-catenin has been impli-
cated in a variety of human cancers, including glioblastoma
multiforme (GBM), the most malignant form of glioma (Zheng
et al., 2010). Unlike colorectal cancer, in which high levels of
b-catenin are frequently found as a result of mutational loss ofn human cancers and is critical for cancer formation. A key
tion, for which the underlying molecular mechanisms remain
ost human tumors, is a critical component of Wnt signaling
oxM1 directly interacts with b-catenin and is necessary and
tion in tumor cells. The FoxM1 and b-catenin interaction is
uired for glioma formation. This interaction provides insights
of this important pathway.
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Figure 1. FoxM1 and b-Catenin Directly Interact In Vitro and In Vivo
(A) 293T cells were transfected with Flag-FoxM1 or a control plasmid. Cell extracts were subjected to IP using an anti-Flag antibody. The IP protein complex
was subjected to LC-MS/MS analysis. Four identified peptide sequences of b-catenin are shown.
(B) GST pull-down was performed using purified GST-b-catenin and 6xHis-FoxM1, followed by IB with an anti-His antibody (left panel). IP was performed using
purified 6xHis-FoxM1 and GST-b-catenin with an anti-FoxM1 antibody, followed by IB with anti-FoxM1 and anti-b-catenin antibodies (right panel).
(C) Western blotting of the FoxM1 protein in eight cell types, including five established GICs and two glioma cell lines.
(D) Cells were transfected with the TOP-Flash or control FOP-Flash reporter to determine reporter activities 48 hr after transfection. Promoter activation (fold)
was calculated relative to that in 293T cells. Values are mean ± SD for triplicate samples.
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FoxM1 Promotes b-Catenin Nuclear Localizationthe adenomatous polyposis coli (APC) gene or stabilizing muta-
tions in the CTNNB1 (b-catenin) gene itself (Polakis, 2000), in
sporadic gliomas, the frequency of APC loss or CTNNB1 muta-
tions appears to be low (Paraf et al., 1997). This suggests that
genetic mutations may not be the major driving force leading
to elevated b-catenin nuclear accumulation and, hence, activa-
tion in GBM. Importantly, the Wnt/b-catenin pathway is known
to critically regulate self-renewal and differentiation of neural
stem/progenitor cells (Chenn and Walsh, 2002; Nusse, 2008).
These findings prompted us to examine the molecular mecha-
nism of Wnt/b-catenin signaling activation and its potential role
in tumorigenicity of GBM-initiating cells (GICs).
Like b-catenin, the forkhead box M1 (FoxM1) transcription
factor is an important regulator of animal development and
cell proliferation (Korver et al., 1998; Ye et al., 1997). Further-
more, overexpression of FoxM1 is common in human tumors
(Pilarsky et al., 2004), including glioma (Liu et al., 2006). Thus,
gene expression analyses by the Cancer Genome Atlas
(TCGA) found FoxM1 to be overexpressed in GBM clinical spec-
imens compared with nontumor controls (Hodgson et al., 2009).
Because overactivation of FoxM1 and b-catenin occurs in many
human cancers, we are interested in potential functional
connections between these two intensively studied oncogenic
pathways. There is evidence that FoxM1 and b-catenin may
have related or common functions in tumor. For example, gut-
specific deletion of FoxM1 suggests its key role in gastrointes-
tinal tumorigenesis and potential regulation of b-catenin/TCF4
signaling (Yoshida et al., 2007). However, because FoxM1 and
b-catenin both have pleiotropic roles, it is unclear whether a
common molecular mechanism underlies these related pheno-
types. In the current study, we explored the possibility of
FoxM1 as a key component in mediating b-catenin nuclear
accumulation in Wnt signaling and determined the biological
consequence of FoxM1–b-catenin interaction in brain tumor
formation.
RESULTS
FoxM1 Interacts Directly with b-Catenin In Vitro
and In Vivo
A Flag-tag affinity procedure was used to purify a FoxM1-
containing complex, which was subjected to LC-MS/MS anal-
ysis. The peptide sequences of b-catenin found in the complex
suggested that b-catenin is a potential binding partner of
FoxM1 (Figure 1A and Figures S1A and S1B, which are available
with this article online). The interaction between b-catenin
and FoxM1 was confirmed by immunoprecipitation (IP) analysis
of 293T cells transfected with HA-tagged b-catenin and
Flag-FoxM1 (Figure S1C). The physical interactions between
b-catenin and FoxM1 were further analyzed in vitro using re-(E) Nuclear extracts of MD11 and MD20s cells were subjected to IP using FoxM1
Reciprocal IP was done using b-catenin antibody or control IgG, followed by IB
(F) Lysates of Hs683 and SW1783 cells that stably express T7-FoxM1 or a contro
by IB with anti-b-catenin or anti-TCF4 antibodies.
(G) 293T cells were cotransfected with Flag-FoxM1 and HA-b-catenin plasmids. T
were prepared at the indicated time points and subjected to IP and IB analy
for cytoplasmic and nuclear fractions, respectively.
See also Figure S1.
Ccombinant GST-b-catenin and His-FoxM1. In a GST pull-down
assay, purified His-FoxM1 bound directly to GST-b-catenin (Fig-
ure 1B, left). Reciprocally, in an IP assay using an anti-FoxM1
antibody, GST-b-catenin also bound to His-FoxM1 (Figure 1B,
right). Thus, b-catenin binds to FoxM1 directly in vitro.
We detected endogenous FoxM1 expression in 293T cells,
human glioma cell lines Hs683 and SW1783 (grade III), and
a panel of GIC cell lines (MD 11, 20 s, 23, 7-2, and 6-27). These
GICs are primary neurosphere-derived cells isolated from fresh
surgical specimens of GBM and have an enriched GIC popula-
tion (Figures S1D–S1G). FoxM1B is the predominant FoxM1
isoform in 293T cells and in the human glioma cells, including
the GICs (Figures S1H–S1J). Moreover, GICs expressed sub-
stantially higher levels of FoxM1 than did Hs683 and SW1783
cells (Figure 1C). Furthermore, Wnt activity was substantially
higher in GICs than in Hs683 and SW1783 cells, as determined
using the TOP-Flash reporter (Figure 1D), indicating that Wnt
activity is deregulated and correlated with the FoxM1 levels in
the cells.
We next determined whether b-catenin and FoxM1 interact in
glioma cells. In MD11 and MD20s cells, endogenous FoxM1
bound to endogenous b-catenin, as determined by co-IP assays
(Figure 1E). When Hs683 and SW1783 cells overexpressed
T7-tagged FoxM1, endogenous b-catenin bound to FoxM1
(Figure 1F, left) and T7-FoxM1 (Figure 1F, right). Moreover,
endogenous TCF4 protein, a well-known binding partner and
transcriptional target of b-catenin, could be detected in the
FoxM1 and T7-FoxM1 precipitates, and its level was increased
upon FoxM1 overexpression (Figure 1F). Thus, b-catenin and
FoxM1 interact in tumor cells. We also examined the specificity
of FoxM1 isoforms interacting with b-catenin and found that
the FoxM1B binding ability is higher than that of FoxM1C
(Figures S1K and S1L).
Wnt Promotes Nuclear Translocation of Both FoxM1
and b-Catenin
Because Wnt3a is known to stabilize b-catenin and increase its
nuclear accumulation, we examined the interaction of FoxM1
with b-catenin upon Wnt3a stimulation in 293T cells that had
been cotransfected with HA-b-catenin and Flag-FoxM1. The
amount of b-catenin that bound to FoxM1 in the nucleus
increased substantially with Wnt3a treatment in a time-depen-
dent manner (Figure 1G). Surprisingly, the amount of Flag-
FoxM1 that translocated to the nucleus also increased with
Wnt3a treatment in a time-dependent manner (Figure 1G).
Thus, b-catenin interacts with FoxM1 in both the cytoplasm
and the nucleus, and Wnt activation increases the translocation
of both proteins to the nucleus.
To further investigate the nuclear translocation of FoxM1 and
b-catenin during Wnt activation, we cotransfected 293T cellsantibody or control IgG, followed by IB with b-catenin antibody (upper panels).
with the FoxM1 antibody (lower panels).
l vector were subjected to IP using anti-FoxM1 or anti-T7 antibodies, followed
he cells were treated with 20 ng/ml Wnt3a, and cytoplasmic or nuclear extracts
ses with the indicated antibodies. Tubulin and TFIIb were used as controls
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FoxM1 Promotes b-Catenin Nuclear Localizationwith DsRed2-N1-FoxM1 and CFP-b-catenin and monitored the
fluorescence intensities by time-lapse live imaging of the cells
treated with Wnt3a every 10 s for 10 min. We reasoned that,
during this early time window of Wnt treatment, we would
observe primarily b-catenin translocation rather than stabiliza-
tion of b-catenin that was already present as a result of overex-
pression. FoxM1 and b-catenin were colocalized in both the
cytoplasm and nucleus, and Wnt3a increased the levels and
nuclear translocation of both proteins (Figure 2A and Figure S2A).
The fluorescence intensities of both proteins increased with time
in the nuclei of Wnt3a-treated cells (Figure 2B). Note that the
nuclear translocation of both proteins was probably underesti-
mated, considering the effect of photo-bleaching during live
imaging (Figure S2B). Indeed, Wnt3a promoted the nuclear
translocation of endogenous FoxM1 and b-catenin (Figure 2C)
and increased FoxM1 levels (Figure 2D) in 293T cells, as deter-
mined by immunoblotting (IB) analysis. Wnt3a also promoted
the nuclear translocation of endogenous FoxM1 and b-catenin
and increased FoxM1 levels in MD11 cells, as determined by
immunofluorescence (IF) analysis (Figure 2E). Thus, Wnt activa-
tion increases the level and nuclear translocation of FoxM1,
indicating that FoxM1 is a downstream component of Wnt
signaling. However, FoxM1 mRNA levels did not increase
upon Wnt3a treatments in MD11 cells (Figure S2C). Next, we in-
hibited new protein synthesis in the cells by cycloheximide and
found that Wnt3a treatment resulted in a decrease in the endog-
enous FoxM1 degradation compared with control treatment
(Figure 2F). These results indicated that Wnt3a increased
FoxM1 levels through, at least in part, inhibition of FoxM1 protein
degradation.
FoxM1 Is Required for b-Catenin Nuclear Localization
in Tumor Cells
FoxM1 contains a functional nuclear localization signal (NLS)
domain and shuttles between the cytoplasm and the nucleus
(Ma et al., 2005). Because the amount of b-catenin that bound
to FoxM1 was directly proportional to the amount of FoxM1 in
the nucleus (Figure 1G), we examined whether FoxM1 plays
a role in b-catenin nuclear localization. Expression levels of
the endogenous FoxM1 and b-catenin increased in the cyto-
plasm and nucleus of Wnt3a-treated cells (Figure 3A), consistent
with the findings of the IP assay (Figure 1G), of live imaging
of the Wnt3a-treated 293T cells (Figures 2A and 2B), and of
the IF assay of the Wnt3a-treated MD11 cells (Figure 2E). Over-
expression of Flag-FoxM1 was sufficient to increase nuclear
b-catenin while concomitantly decreasing cytoplasmic b-catenin
(Figure 3A). These data suggest that the FoxM1 expression
level is increased upon Wnt signaling and that increased
expression of FoxM1 directly increases b-catenin nuclear
accumulation.
To ascertain the role of FoxM1 in b-catenin nuclear accumula-
tion, we examined b-catenin nuclear localization in FoxM1 null
cells. Deletion of FoxM1 in FoxM1fl/fl immortalized neural stem
cells (NSCs) did not change the total level of b-catenin expres-
sion but abolished b-catenin nuclear localization (Figures 3B
and 3C). Moreover, b-catenin nuclear localization induced by
Wnt3a was abolished in FoxM1 null immortalized MEFs derived
from FoxM1/ mice (Figure 3D). These results suggest that
FoxM1 is critical for b-catenin nuclear localization.430 Cancer Cell 20, 427–442, October 18, 2011 ª2011 Elsevier Inc.Consistently, knockdown of FoxM1 by a FoxM1-siRNA, or
via two independent FoxM1-shRNAs (Liu et al., 2006), in MD11
and MD20s cells substantially decreased the levels of nuclear
b-catenin as determined by IB and IF analyses (Figures 3E–
3G). In contrast, when FoxM1 expression was restored in sh-
FoxM1 MD11 cells, b-catenin nuclear localization was restored
(Figure 3G).
We also analyzed the effect of reducing FoxM1 on Wnt3a-
induced b-catenin nuclear localization in glioma cells. Wnt3a
increased b-catenin nuclear accumulation in MD11 and MD20s
cells expressing the control shRNA (Figure 3H). In contrast,
expression of either of the two shRNAs against FoxM1 abolished
Wnt3a-induced b-catenin nuclear but not cytoplasmic accu-
mulation (Figure 3H). Conversely, overexpression of FoxM1
counteracted the inhibitory effect of Wnt antagonist DKK1 on
b-catenin nuclear accumulation (Figure S2D). Thus, these data
indicate that FoxM1 does not affect b-catenin level but is
required for b-catenin nuclear accumulation in tumor cells.
FoxM1 Nuclear Translocation and Binding to b-Catenin
Are Required for FoxM1-Mediated b-Catenin Nuclear
Accumulation in Tumor Cells
b-Catenin consists of an NH2-terminal domain, a central arma-
dillo (Arm) repeat domain (residues 141–664) composed of 12
Arm repeats, and a COOH-terminal domain (residues 664–782)
(Figure 4A, left). Using a series of bacterially expressed GST-
b-catenin deletion mutant proteins, we found that Arm repeats
11–12 of b-catenin interacted with FoxM1 (Figure 4A, right).
FoxM1 consists of an NH2-terminal domain, a conserved fork-
head box domain (residues 232–332), an NLS domain (residues
350–366), and a COOH-terminal domain (Figure 4B, left). We
found that the forkhead box domain of FoxM1 interacted with
b-catenin (Figure 4B, right). Also, co-IP experiments in 293T cells
revealed that b-catenin bound to FoxM1 mutants harboring the
forkhead box domain but not to mutants without it (Figure 4C).
An artificial fusion protein between the forkhead box domain
and the SV40 NLS (235-347+NLS) was sufficient for binding to
b-catenin (Figure 4C).
Next, we determine the effect of FoxM1 mutants on b-catenin
nuclear accumulation. b-Catenin accumulated in the nuclei of
cells expressing full-length FoxM1 or the mutant with both the
forkhead box and NLS domains (Figure 4D). In contrast, b-cate-
nin failed to accumulate in the nuclei of cells expressing FoxM1
mutants lacking the forkhead box domain. The FoxM1 mutant
without the NLS domain impaired the nuclear accumulation of
both FoxM1 and b-catenin. Importantly, the fusion fragment
235-347+NLS promoted the nuclear accumulation of both the
FoxM1mutant and b-catenin (Figure 4D). Thus, the nuclear local-
ization of b-catenin depends on the interaction of b-catenin with
FoxM1 and on FoxM1 nuclear translocation.
FoxM1–b-Catenin Interaction Is Required for
b-Catenin–TCF-Mediated Transcription and for the
Expression of b-Catenin Target Genes in Tumor Cells
It is well established that nuclear b-catenin associates with
members of the TCF/LEF family of DNA-bound transcription
factors on TCF-binding elements (TBEs), also called Wnt-
responsive elements (WREs), to mediate Wnt target gene
expression (Clevers, 2006; Moon et al., 2004). We used the
Figure 2. FoxM1 Promotes b-Catenin Nuclear Accumulation
(A, B) 293T cells were transfected with DsRed2-N1-FoxM1 plus CFP-b-catenin for 48 hr and then treated with 20 ng/ml Wnt3a. Sequential live images of FoxM1
and b-catenin nuclear localization/colocalization were taken every 10 s after Wnt3a treatment using a confocal imaging system.
(A) DsRed or CFP fluorescence intensities of the cells at each time point (0, 5, and 10 min) are shown as pseudocolor images. The white spots (colocalization
points) of merged DsRed and CFP images indicate that FoxM1 and b-catenin colocalized in the cell (scale bar, 10 mm). The boxed area in the nucleus is shown
at higher magnification in the upper right corner.
(B) Three positions in the nucleus were randomly chosen, and fluorescence intensities at these positions were calculated for each time point.
(C) Nuclear levels of b-catenin and FoxM1 in 293T cells treated with 20 ng/ml Wnt3a for indicated times were analyzed by IB.
(D) Total levels of b-catenin and FoxM1 in 293T cells treated with 20 ng/ml Wnt3a for indicated times were analyzed by IB.
(E) MD11 spheres were dissociated and plated on coverslips precoated with poly-L-ornithine and fibronectin in serum-free media with EGF and bFGF for 48 hr.
The cells were then treated with control PBS or Wnt3a (20 ng/ml) for 4 hr. Cytoplasmic and nuclear levels of FoxM1 and b-catenin in the cells were analyzed
by triple IF staining (scale bar, 40 mm).
(F) MD11 cells were treated with cycloheximide (CHX, 50 mg/ml) and with or without Wnt3a (20 ng/ml) at the indicated time points. Cell extracts were prepared
and analyzed by IB.
See also Figure S2.
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Figure 3. FoxM1 Is Required for Constitutive and Wnt3a-Induced b-Catenin Nuclear Accumulation
(A) Cytoplasmic and nuclear levels of FoxM1 and b-catenin in 293T cells transfected with increasing amounts of the Flag-FoxM1 expression plasmid were
analyzed by IB. The cells treated with 20 ng/ml Wnt3a for 60 min were used as a positive control.
(B and C) FoxM1/ NSCs were generated by isolation of primary NSCs (from FoxM1fl/fl mice), which were immortalized with the SV-40 large-T antigen and then
infected with Ad-Cre to delete the floxed alleles of FoxM1. Cytoplasmic and nuclear levels of FoxM1 and b-catenin in immortalized FoxM1fl/fl and FoxM1/NSCs
were analyzed by IF (B) and IB (C).
(D) FoxM1/ or FoxM1+/+ MEFs were immortalized with the SV-40 large-T antigen. They were then treated with Wnt3a (20 ng/ml) for the indicated times.
Cytoplasmic and nuclear levels of FoxM1 and b-catenin were analyzed by IB.
(E) Nuclear levels of FoxM1 and b-catenin were examined in MD11 and MD20s cells that were treated with two different amounts of the FoxM1 or control siRNA.
(F) Nuclear levels of FoxM1 and b-catenin were examined in MD11 and MD20s cells that stably express two different shRNAs for FoxM1 (sh-FoxM1-1 or sh-
FoxM1-2) or a control shRNA (sh-control).
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FoxM1 Promotes b-Catenin Nuclear LocalizationTOP-Flash reporter to ascertain whether FoxM1 and its mutants
affect b-catenin–TCF/LEF transcriptional activity. Interestingly,
overexpression of full-length FoxM1 alone strongly activated
the TOP-Flash reporter, and thus the transcriptional activity of
b-catenin–TCF (Figure 4E). This TOP-Flash activation was prob-
ably mediated by engaging endogenous TCF and b-catenin,
because FoxM1 overexpression increased levels of TCF4
(Figure 1F) and nuclear b-catenin (Figure 2F). A FoxM1 mutant
containing the forkhead box and NLS domains stimulated
TOP-Flash, whereas FoxM1 mutants lacking the forkhead box
domain or the NLS domain did not (Figure 4E). Importantly, the
FoxM1 fragment 235-347+SV40NLS also stimulated TOP-Flash
activity (Figure 4E). Thus, the ability of FoxM1 to activate the
b-catenin–TCF transcriptional function correlates fully with
FoxM1-mediated b-catenin nuclear translocation.
To distinguish the action of FoxM1 as a b-catenin partner from
the possibility that FoxM1 acts as a DNA-binding transcription
factor, we generated the FoxM1 R286A/H287A mutant, which
is incapable of DNA binding, as predicted from crystal structure
studies (Littler et al., 2010). Indeed, this mutant dramatically
decreased the ability of FoxM1 to activate a reporter from
multimerized FoxM1-binding elements (Figure S3A) as well as
decreased the ability to bind to FoxM1 response elements
in the c-Myc promoter (Figure S3C). However, this mutant
maintained the same ability to promote b-catenin nuclear local-
ization (Figure 5A), bind to the b-catenin–TCF-binding elements
in the c-Myc promoter (Figure S3D), and activate the b-cate-
nin–TCF reporter (Figure S3B), indicating that the effect of
FoxM1 on b-catenin–TCF transcriptional activity depends on
interaction with b-catenin but not on FoxM1’s own DNA-binding
property.
We next determined whether FoxM1 is required for b-catenin–
TCF-mediated transcription. As with FoxM1 overexpression,
a constitutively stabilized mutant b-catenin (S33Y) activated
TOP-Flash, which was inhibited by the FoxM1 siRNA in 293T
cells (Figure 5B), suggesting that FoxM1 is required for b-catenin
signaling. Conversely, dominant-negative TCF4 (DN-TCF4),
which cannot bind to b-catenin, abolished the activation of
TOP-Flash by FoxM1 (Figure 5B), suggesting that the effect of
FoxM1 is mediated by binding of b-catenin to TCF4. Knocking
down FoxM1 also suppressed the activation of the TOP-Flash
reporter in MD11 and MD20s cells, likely as a result of endoge-
nous b-catenin–TCF signaling (Figure 5C).
We further examined several endogenous and prototypicWnt/
TCF/b-catenin target genes. Expression levels of Axin2, LEF-1,
c-Myc, and cyclin D1 were increased inMD20s cells that overex-
pressed FoxM1 (Figure 5D) and were decreased in MD11 and
MD20s cells with knocking down of FoxM1 (Figure 5E) and in
NSCs with genetic deletion of FoxM1 (Figure 5F). Furthermore,
overexpression of the FoxM1 R286A/H287A mutant increased
the expression of Axin2 in 293T cells (Figure 5G), indicating
that the effect of FoxM1 onWnt target gene expression depends
on interaction with b-catenin.(G) Triple IF staining for FoxM1 (red), b-catenin (green), and nuclei (DAPI, blue) w
cells that were transiently transfected with a pcDNA3.1-FoxM1 plasmid. Note tha
nuclear localization (scale bar, 25 mm).
(H) MD11 and MD20s cells that stably express sh-FoxM1 or sh-control were trea
extracts.
CMutual Recruitment of FoxM1 and b-Catenin to Wnt
Target-Gene Promoters
Because FoxM1 is required for activation of Wnt target genes
and can form a complex with nuclear b-catenin and TCF4,
FoxM1 might be recruited to TBEs/WREs in chromatin. We first
determined whether FoxM1 regulates the LEF-1 promoter,
which contains three WREs (Figure 6A). Overexpression of
FoxM1 in 293T cells increased the activity of the wild-type
LEF-1 promoter but not the mutant LEF-1 promoter, which
harbors three mutated WREs (Figure 6A), suggesting that
FoxM1 activates the promoter via the WREs. Moreover,
FoxM1, b-catenin, and TCF4 bound to the WRE region of
LEF-1 promoter in MD11 cells (Figure 6B). Furthermore, Wnt3a
stimulation caused a dramatic increase in FoxM1 and b-catenin
binding to the LEF-1 promoter, which was occupied by TCF4
constitutively in 293T cells (Figure 6C).
Axin2 and c-Myc are also well-known Wnt target genes
(through characterized TBEs/WREs in their promoters) (Clevers,
2006; Moon et al., 2004). We found that in MD11 cells, FoxM1,
b-catenin, and TCF4 were recruited to the endogenous Axin2
promoter (Figure 6D) and also to a transfected c-Myc promoter
harboring wild-type TBEs (TBE1/2) but not to a c-Myc promoter
harboring mutant TBEs (TBE1m/2m; Figure 6E). Moreover,
FoxM1 associated with the WREs in the LEF-1 promoter
that had been immunoprecipitated by the anti-b-catenin or
anti-TCF4 antibody (Figure 6F). Together, these results indicate
that FoxM1, b-catenin, and TCF4 are recruited to WREs in Wnt
target-gene promoters as a DNA-binding complex.
Next, we determined whether nuclear FoxM1 plays a role in
assembly of the b-catenin–TCF transcription activation complex.
We observed that association of b-catenin with the LEF-1
promoter was diminished upon FoxM1 depletion (Figure 6G).
Next, we examined the effect of FoxM1 depletion on the binding
between b-catenin and TCF4 using exogenous Myc-TCF4
(because TCF4 is a target gene of FoxM1). We found that the
binding between b-catenin and TCF4 was decreased upon
FoxM1 depletion (Figure 6I). Thus, the decreased association of
b-catenin with the LEF-1 promoter upon FoxM1 depletion was
probably because both the nuclear b-catenin level (Figure 3E)
and the binding between b-catenin and TCF4 were decreased
(Figure 6I). These results indicate that FoxM1 is important for
assembly of the b-catenin–TCF transcription activation complex.
Given the binding between b-catenin and FoxM1, we also
examined whether b-catenin is required for FoxM1 binding to
theWnt target-gene promoter. Depletion of b-catenin diminished
the binding of FoxM1 to the LEF-1 promoter (Figure 6H). More-
over, depletion of b-catenin by a siRNA or genetic deletion
reduced or abolished the association between FoxM1 and
TCF4 (Figures 6J and 6K), indicating that the association of
FoxM1 with TCF4 is mediated by b-catenin. Collectively, the
above results suggested that FoxM1 and b-catenin mutually
depend on each other for recruitment to WREs occupied by
TCF4 in Wnt target-gene promoters.as performed in sh-FoxM1 and sh-control MD11 cells and in sh-FoxM1 MD11
t restoration of FoxM1 expression in sh-FoxM1 MD11 cells restores b-catenin
ted with 50 ng/ml Wnt3a for 2 hr. IB was performed on cytoplasmic or nuclear
ancer Cell 20, 427–442, October 18, 2011 ª2011 Elsevier Inc. 433
Figure 4. FoxM1 Nuclear Translocation and Binding to b-Catenin Are Required for FoxM1-Mediated b-Catenin Nuclear Accumulation
(A) Schematic illustration of b-catenin deletionmutants (left panel) and aGST pull-down experiment using bacterially expressed and purifiedwild-type andmutant
b-catenin as GST-fusion proteins and His-FoxM1 (right panel).
(B) Schematic illustration of FoxM1 deletion mutants (left panel) and IP using bacterially expressed and purified His-tagged wild-type andmutant FoxM1 proteins
and GST-b-catenin (right panel).
(C) Schematic illustration of Flag-FoxM1 deletion mutants in a mammalian expression system (left panel). Lysates from 293T cells expressing the Flag-FoxM1
mutants and HA-b-catenin were subjected to IP (right panel).
(D) 293T cells expressing Flag-FoxM1 or mutants were processed for triple IF staining for Flag-FoxM1 (red), b-catenin (green), and nuclei (DAPI, blue). White
arrows indicate colocalization of FoxM1 and b-catenin in nuclei (scale bar, 10 mm).
(E) 293T cells were cotransfected with Flag-FoxM1 or mutants plus the TOP-Flash or control FOP-Flash luciferase reporter. The ratios between TOP-Flash and
FOP-Flash were determined 48 hr after transfection, and promoter activation (fold) was calculated relative to that in cells transfected with the control vector.
Values are mean ± SD for triplicate samples from a representative experiment.
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Figure 5. FoxM1 Activates Wnt/b-Catenin Signaling
(A) IB analysis of cytoplasmic and nuclear levels of b-catenin and FoxM1 in 293T cells that were transfected with a vector (Control), FoxM1 wild-type (WT), or
FoxM1 with mutations at Arg-286 and His-287 (R286A/H287A) plasmid.
(B)Mutual dependence of FoxM1 and b-catenin in activating the TOP-Flash reporter. FOP-Flashwas used as negative control. 293T cells were cotransfectedwith
Flag-FoxM1, b-catenin S33Y, DN-TCF4 expression plasmid, FoxM1-siRNA, or combinations as indicated. Values are mean ± SD for triplicate samples. Cells
treated with 20 ng/ml Wnt3a for 12 hr were used as a positive control.
(C) Activities of TOP-Flash or FOP-Flash in MD11 andMD20s cells cotransfected with an increasing amount of FoxM1-siRNA. Values are mean ± SD for triplicate
samples.
(D) Cellular levels of FoxM1, b-catenin, Axin2, LEF-1, and c-Myc in MD20s cells transfected with a vector or FoxM1 expression plasmid were analyzed by IB.
(E) Cellular levels of FoxM1, b-catenin, Axin2, LEF-1, and c-Myc in MD11 or MD20s cells transfected with control-siRNA or FoxM1-siRNA were examined by IB.
(F) Cellular levels of FoxM1, b-catenin, Axin2, LEF-1, c-Myc, and cyclin D1 in FoxM1-knockout NSCs were examined by IB.
(G) Cellular levels of FoxM1, b-catenin, and Axin2 in 293T cells transfected with a vector (control), FoxM1 (WT), or FoxM1 R286A/H287A plasmid.
See also Figure S3.
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Figure 6. Mutual Recruitment of FoxM1 and b-Catenin to Wnt Target-Gene Promoters
(A) FoxM1 activates the LEF-1 promoter via theWREs. The threeWREs of the LEF-1 promoter were mutated to generate the mutant LEF-1 promoter. The relative
luciferase activity of wild-type (WT) or mutant (Mut) LEF-1 promoters was determined in 293T cells transfected with the FoxM1 or control vector. Values are
mean ± SD for triplicate samples.
(B and C) ChIP assays on WREs of LEF-1 promoter or the ORF region of LEF-1 gene were performed in MD11 cells (B) or 293T cells with or without Wnt3a
treatment (20 ng/ml) for 6 hr (C).
(D) ChIP assays on WREs of Axin2 promoter or the ORF region of Axin2 gene were performed in MD11 cells.
(E) A luciferase reporter driven by the c-Myc promoter with wild-type TBEs (pBV-TBE1/2-luc) or mutant TBEs (pBV-TBE1m/2 m-luc) was transfected into MD11
cells. Then ChIP assays were performed using PCR primer pairs flanking the c-Myc promoter (on the pBV vector).
(F) FoxM1 and b-catenin co-occupied the LEF-1 promoter in MD11 cells.
(G and H) ChIP assays were performed in MD11 cells that were transfected with FoxM1-siRNA, b-catenin-siRNA, or control siRNA.
(I) Co-IP analyses of b-catenin–TCF4 interaction in 293T cells that were cotransfected with Myc-TCF4 and increasing amounts of FoxM1-siRNA and treated with
20 ng/ml Wnt3a for 6 hr.
(J and K) Co-IP analyses of the association of FoxM1 with TCF4 in 293T cells that were cotransfected with Flag-FoxM1, Myc-TCF4, and b-catenin-siRNA (J) or in
b-catenin/ MEFs (K).
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Figure 7. FoxM1 and b-Catenin Maintain
GIC Self-Renewal and Glioma Formation
(A) Photographs of primary and secondary neu-
rosphere formation of MD11 cells that express
shRNAs for control, FoxM1, or b-catenin. Scale
bar, 100 mm.
(B) The primary and secondary neurosphere
formation efficiency (spheres/cells plated) of the
cells in (A). Values are mean ± SD for triplicate
samples. shR: shRNA-resistant FoxM1 (or its
mutant).
(C) Dissociated MD11 cells from spheres were
plated on coverslips precoated with poly-L-orni-
thine and fibronectin, and the indicated markers
were examined via IF (scale bar, 40 mm).
(D and E) MD11 or MD20s cells (53 103 or 13 105
cells/mouse) that express the indicated shRNAs
were implanted intracranially in nude mice. Mice
were killed when they were moribund or 120 days
after implantation. Tumor formation was deter-
mined by histology. Tumor-initiating frequency
was then calculated (D). Survival of mice (n = 5)
was evaluated by Kaplan-Meier analysis (E). *p <
0.001.
(F) ShRNA-resistant R286A/H287A mutant or
b-catenin-NLS rescued the tumor-initiating ca-
pacity of GICs that express the FoxM1-shRNA.
MD11 or MD20s-shFoxM1 cells (1 3 105 cells/
mouse) that express shRNA-resistant FoxM1 wt,
shRNA-resistant R286A/H287A, or b-catenin-NLS
were implanted intracranially in nude mice. Mice
were killed when they were moribund or 70 days
after implantation. Tumor-initiating frequency was
then calculated.
See also Figure S4.
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in GIC Self-Renewal and Differentiation
To study the effect of FoxM1 and b-catenin on the self-renewal of
GICs, we generated primary cultures of tumor cells (PCTCs) in
the presence of serum, and in parallel, neurospheres from
human GBM samples. The neurospheres showed enrichment
for GICs, because, first, they maintained neurosphere formation
ability and thus exhibited self-renewal ability (Lee et al., 2006;
Singh et al., 2003) (Figure S4A); second, they expressed high
levels of the neuroprogenitor markers Nestin, CD133, and
SSEA-1 (Figure S4D); and third, they could undergo multilineage
differentiation, acquiring the expression of GFAP (astrocytic
marker) and Tuj-1 (neuronal marker) (Figures S4B and S4C).Cancer Cell 20, 427–442,Importantly, high levels of FoxM1 (Fig-
ure S4D) and Wnt reporter activity (Fig-
ure S4E) were present in these GICs
compared with the PCTCs. Thus, we
investigated whether FoxM1 and b-cate-
nin were required for GIC self-renewal.
Knockdown of FoxM1 or b-catenin in
MD11 and MD20s cells substantially
decreased the size and number of
spheres formed in primary and secondary
sphere formation assays (Figures 7A
and 7B). Next, the cells were assayed
for neural colony-forming ability, a morestringent test for the presence of self-renewing cells (Louis
et al., 2008). Knockdown of FoxM1 or b-catenin substantially
reduced the efficiency of neural colony formation in GICs
(Figures S4F). Moreover, the inhibitory effect of sh-FoxM1 on
self-renewal of GICs was rescued by shRNA-resistant R286A/
H287A, which binds to b-catenin but not to FoxM1-response
elements or b-catenin-NLS (which translocates into the nucleus
constitutively) (Figure 7B and Figure S4F).
We investigated whether FoxM1 and b-catenin also affect
GIC differentiation. FoxM1 knockdown substantially inhibited
the expression of CD133, Nestin, Sox2, and Musashi-1 and
up-regulated the differentiation markers of Tuj1 and GFAP in
GICs (Figure 7C and Figure S4G). Depletion of b-catenin inOctober 18, 2011 ª2011 Elsevier Inc. 437
Figure 8. Interaction of FoxM1 and b-Catenin Controls Glioma Formation
(A) The tumorigenicity of SW1783 or Hs683 cells that stably express vector, FoxM1, FoxM1+sh-control, or FoxM1+sh-b-catenin and the survival of the mice were
evaluated as described in Figure 7D. *p < 0.001 and **p < 0.01.
(B) Sections of tumors produced by SW1783-FoxM1 cells or brain tissue frommice injected with SW1783-vector cells were IF-stained with FoxM1 and b-catenin
antibodies, followed by confocal microscopic analysis.
(C) The tumorigenicity of SW1783 or Hs683 cells that stably express vector, FoxM1, or FoxM1 R286A/H287A and the survival of the mice. *p < 0.001.
(D) Cellular levels of b-catenin, LEF-1, Axin2, c-Myc, and cyclin D1 (left panel) and activities of TOP-Flash or FOP-Flash (right panel) in SW1783 cells that stably
express vector, FoxM1, FoxM1+sh-control, or FoxM1+sh-b-catenin. Values are mean ± SD for triplicate samples.
(E) Cellular levels of b-catenin, LEF-1, Axin2, c-Myc, and cyclin D1 (left panel) and activities of TOP-Flash or FOP-Flash (right panel) in SW1783 cells that stably
express vector, FoxM1, or FoxM1 R286A/H287A. Values are mean ± SD for triplicate samples.
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FoxM1 perturbed the balance between progenitor cell renewal
and the commitment to differentiation. Moreover, these effects
of sh-FoxM1 were rescued by shRNA-resistant R286A/H287A
or b-catenin-NLS (Figure S4I), supporting that FoxM1–b-catenin
interaction controls the self-renewal of GICs.
Next, we examined the cell-cycle progression of the above
cell lines. An endogenous FoxM1-b-catenin complex and Wnt
signal activity were observed in asynchronous GICs and in
GICs in cell-cycle phases G0/G1, S, and G2/M, with a relatively
higher level seen in G2/MGICs (Figures S4M–S4O). Comparison
of cell-cycle profiles of the above cell lines revealed a similar
cell-cycle distribution under asynchronous conditions (Fig-
ure S4P). However, when synchronized and released from
G1/S transition, sh-FoxM1GICs exhibited a delay inmitotic entry
(Figure S4P). Depletion of b-catenin in GICs also resulted in
G2/M arrest (Figure S4P). Expression of shRNA-resistant
R286A/H287A or b-catenin-NLS in sh-FoxM1 cells partially
restored normal cell-cycle progression. Therefore, these data
indicated that the FoxM1/b-catenin interaction is required for
G2/M transition and proper mitotic progression.
Interaction of FoxM1 and b-Catenin Controls Tumor
Formation by Glioma Cells
Next, we examined the effect of FoxM1 or b-catenin depletion
and their interaction on the tumor-initiating ability of GICs in an
animal model. All mice injected with sh-control MD11 and
MD20s cells displayed brain tumors that showed characteristic
GBM features. In contrast, mice bearing sh-FoxM1 cells did
not develop brain tumors. Therefore, the tumor-initiating ability
was substantially reduced in cells with suppressed FoxM1
expression (100% decrease, Figure 7D). The tumor-initiating
ability was also substantially reduced by suppressed b-catenin
expression (Figure 7D). In addition, the mice bearing sh-FoxM1
or sh-b-catenin cells survived significantly longer than controls
(Figure 7E and Figure S4J). Moreover, FoxM1, b-catenin, and
Wnt signal activity levels were highly elevated in the brain tumor
cells (Figures S4K, S4L, and S4Q), and the proteins colocalized
in tumor cell nuclei (Figure S4K). Furthermore, the inhibitory
effect of sh-FoxM1 on tumorigenicity of GICs was rescued by
shRNA-resistant R286A/H287A or b-catenin-NLS (Figures 7F).
These results support a role for the FoxM1–b-catenin complex
in the induction of GBM in vivo.
To further ascertain that b-catenin mediates the tumorigenic
effect of FoxM1, we examined the tumorigenicity of glioma cells
that overexpress FoxM1 but are deficient in b-catenin. First,
overexpression of FoxM1 promoted SW1783 cells to exhibit
GIC characteristics, because SW1783-FoxM1 cells (but not con-
trol SW1783) were able to form neurospheres and expressed
SSEA-1 and Nestin (Figure S5A). Second, SW1783 and Hs683
cells did not form brain tumors in nude mice, but SW1783-
FoxM1 and Hs683-FoxM1 cells did (Figure 8A), indicating that
FoxM1 overexpression is responsible for tumor formation. How-(F) Expression of FoxM1 and b-catenin was examined via IHC staining in 40 G
are shown in three GBM tumor sections. Right: Staining of nuclear FoxM1 or b
by Pearson’s correlation test (r = 0.682; p < 0.001).
See also Figure S5.
Cever, b-catenin knockdown in SW1783-FoxM1 or Hs683-FoxM1
cells diminished their tumorigenicity (Figure 8A), indicating that
FoxM1 tumor promotion depends on b-catenin. Moreover,
in the SW1783-FoxM1 brain tumors, FoxM1 levels were highly
elevated in tumor cell (Figure S5B), b-catenin mostly localized
in the cell nuclei, and it colocalized with FoxM1 (Figure 8B).
Furthermore, overexpression of FoxM1 R286A/H287A was
able to induce tumor formation (Figures 8C). Consistently,
SW1783-FoxM1 and SW1783-R286A/H287A cells exhibited
higher levels of TOP-Flash reporter and Axin2, LEF-1, c-Myc,
and cyclin D1 expression than SW1783 control cells did (Figures
8D and 8E). In contrast, knockdown of b-catenin in SW1783-
FoxM1 cells abolished elevated expression of the reporter and
the Wnt target genes (Figures 8D). Finally, FoxM1 regulates the
nuclear b-catenin level and thus tumor cell growth in mouse
high-grade glioma models (Figures S5G–S5I). Together, these
results show that the FoxM1–b-catenin interaction controls
the expression of Wnt/b-catenin target genes and tumorigenesis
of glioma cells.
Nuclear b-Catenin Expression in Human GBM
Correlates with Levels of Nuclear FoxM1
We analyzed the significance of FoxM1-mediated b-catenin
activation in human GBM using a panel of 40 GBM samples.
FoxM1 was moderately expressed in 14 samples and was highly
expressed in 18 samples. The expression levels of nuclear
FoxM1 directly correlated with those of nuclear b-catenin
(Figures 8F), further supporting the critical role of FoxM1 in
b-catenin nuclear accumulation in human GBM. Also, the
expression levels of Wnt targets Axin2 and LEF-1 directly corre-
lated with the levels of FoxM1 (Figures S5C and S5D).
Next, we performed IF staining on eight frozen GBM tumor
samples that were FoxM1 positive. Sections from the same
tumor tissues were used for costaining for FoxM1 and b-catenin
and for Nestin and GFAP. Nuclear FoxM1 colocalized with
nuclear b-catenin in tumor cells (Figures S5E and S5F). More-
over, FoxM1 expression correlated directly with Nestin expres-
sion but inversely with GFAP expression in tumors (Figure S5F).
Together, our data suggest that, in GBM tumors that express
high levels of FoxM1, b-catenin and FoxM1 probably promote
GIC self-renewal, as evidenced by the increase in the number
of cells expressing neuroprogenitor cell markers.
DISCUSSION
Here, we demonstrate that FoxM1 is required for b-catenin
nuclear accumulation in tumor cells, that nuclear FoxM1 and
b-catenin form a functional complex with TCF4 on Wnt target-
gene promoters, and that the functional interaction between
FoxM1 and b-catenin promotes GIC self-renewal and tumori-
genesis. Therefore, the FoxM1–b-catenin interaction represents
a critical mechanism for controlling canonical Wnt signaling and
GIC self-renewal, proliferation and tumorigenesis.BM specimens. Left: Representative b-catenin and FoxM1 expression levels
-catenin was scored as 1 to 4. The correlation was significant as determined
ancer Cell 20, 427–442, October 18, 2011 ª2011 Elsevier Inc. 439
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Aberrant activation of the Wnt/b-catenin signaling pathway
is widespread in human cancers. In some cancers, such as
colorectal carcinoma, Wnt/b-catenin pathway activation is
caused by mutations in genes encoding Wnt signaling com-
ponents, such as mutational loss of APC or CTNNB1 ‘‘gain-of-
function’’ mutations that increase the stability of b-catenin. In
other cancers, including glioma, which do not exhibit these
prototypic mutations, other mechanisms are likely to be involved
in Wnt/b-catenin activation. Interestingly, FoxM1 is overex-
pressed in many human cancers, including glioma. Our results
show that FoxM1 is an unexpected but key mediator of Wnt/
b-catenin signaling and acts by binding to b-catenin and
enhancing b-catenin nuclear localization and transcriptional
activity.
FoxM1 appears to govern two critical and related aspects of
b-catenin nuclear function: nuclear accumulation and assembly
of a transcription activation complex. The molecular mecha-
nisms for b-catenin nuclear activation during Wnt signaling
remain enigmatic, although several mechanisms have been
proposed. Some studies suggest that b-catenin shuttles from
the cytoplasm to the nucleus by interacting directly with the
nuclear pore complex (Henderson and Fagotto, 2002). Others
suggest that TCF/LEF and b-catenin coactivators such as
Pygopus/Bcl9 mediate b-catenin nuclear import or retention/
anchoring (Townsley et al., 2004).We show that FoxM1 is neces-
sary and sufficient for b-catenin nuclear accumulation. FoxM1
interacts with Arm repeats 10–12 of b-catenin and enhances
b-catenin nuclear localization, whereas depletion of FoxM1
inhibits both constitutive and Wnt3a-induced b-catenin nuclear
localization. Importantly, deletion of the FoxM1 gene in NSCs
abolishes b-catenin nuclear localization. We identified the
minimal FoxM1 domains required for b-catenin nuclear accu-
mulation. The forkhead box domain of FoxM1, which mediates
the binding of b-catenin and FoxM1, and the NLS domain of
FoxM1, which mediates FoxM1 nuclear translocation, are
together necessary and sufficient for b-catenin nuclear accu-
mulation. The simplest interpretation is that FoxM1 provides
a functional NLS domain for nuclear import of the FoxM1–
b-catenin complex. Alternatively, FoxM1 may provide a nuclear
anchor for b-catenin to counteract nuclear export of b-catenin
by other factors, such as APC (Henderson and Fagotto, 2002).
We note a recent study suggesting that EGFR/RAS signaling
promotes b-catenin nuclear accumulation (Phelps et al.,
2009). Interestingly, EGFR/RAS signaling leads to FoxM1 acti-
vation and nuclear translocation (Ma et al., 2005; Park et al.,
2009). The FoxM1–b-catenin signaling axis may underlie these
observations.
In unstimulated cells, b-catenin was found as bothmembrane-
bound and cytoplasmic protein. Recently, it was suggested
that FoxM1 regulates the level of membrane-bound b-catenin
in lung endothelial cells by mediating the transcription of
b-catenin mRNA (Mirza et al., 2010). However, this regulation
seems to be restricted to endothelial cells but not fibroblasts
(Mirza et al., 2010). Consistent with this, we observed that
FoxM1 did not affect the total level of b-catenin expression in
MEFs, NSCs, 293T cells, or glioma cells. The cytoplasmic
pool, but not the membrane-bound pool, of b-catenin rapidly
turns over in unstimulated cells, and Wnt stimulation stabilizes440 Cancer Cell 20, 427–442, October 18, 2011 ª2011 Elsevier Inc.the cytoplasmic pool and induces b-catenin nuclear accu-
mulation (Clevers, 2006; Moon et al., 2004). Our results indi-
cate that FoxM1 is important for promoting b-catenin nuclear
accumulation.
In the nucleus, b-catenin is recruited to promoters of
Wnt target genes through its interaction with TCF/LEF pro-
teins, and the b-catenin–TCF/LEF complex is essential for
transcriptional activation of Wnt target genes. Strikingly, we
also found that nuclear FoxM1 and b-catenin form a tripartite
functional complex with TCF/LEF on Wnt target-gene pro-
moters. FoxM1 and TCF/LEF bind to nonoverlapping Arm
repeats of b-catenin, which mediates the association between
FoxM1 and TCF/LEF. Interestingly, FoxM1 overexpression
can activate the TOP-Flash reporter in a b-catenin–TCF/LEF-
dependent manner. This transactivation ability is independent
of the DNA-binding activity of FoxM1, because a FoxM1
mutant that is incapable of DNA binding can still activate the
TOP-Flash reporter and regulate Wnt-target gene expression.
Furthermore, we found that association of b-catenin with
WREs in chromatin and the binding between b-catenin and
TCF4 were decreased upon FoxM1 depletion. Together, these
findings suggest that FoxM1 promotes not only b-catenin
nuclear accumulation but also the assembly of a FoxM1–b-
catenin–TCF/LEF transcription complex on WREs in chromatin,
thereby playing a central role in Wnt/b-catenin-dependent
transcriptional programs.
FoxM1 has been shown to regulate the cell cycle by binding
to promoters of key cell-cycle genes (Kalinichenko et al., 2004;
Ye et al., 1997). However, because the majority of GICs are in
the G1 phase under asynchronous condition and because
most of the experiments for the effect of FoxM1 on b-catenin
nuclear accumulation and activity were performed in these asyn-
chronous cells, we believe it unlikely that the effect of FoxM1 on
Wnt/b-catenin signaling is the secondary consequence of the
role of FoxM1 in cell cycle. Furthermore, because both FoxM1
and b-catenin knockdowns resulted in a similar G2/M block
in GICs when they are synchronized at the G1/S transition,
and the FoxM1 DNA-binding mutant and a nuclear-localized
b-catenin were each capable of partially rescuing this G2/M
block, we further infer that the effect of FoxM1 on the cell cycle
is, in part, mediated by its association with b-catenin. This is
consistent with the fact that many target genes of b-catenin
signaling have cell-cycle regulatory roles.
FoxM1 Regulation and Wnt Signaling
Recent studies show that FoxM1 is aberrantly activated in many
human cancers and plays an essential role in tumorigenesis
(Kalinichenko et al., 2004; Pilarsky et al., 2004; Yoshida et al.,
2007). Although our findings link FoxM1 to the Wnt/b-catenin
tumorigenic pathway, the mechanism of FoxM1 overexpression
in tumors, including GBM, remains unclear. We showed that
Wnt3a increases both cytoplasmic and nuclear FoxM1 levels
and promotes FoxM1 nuclear accumulation in GBMcells. Others
have shown that GBM cells overexpress the Wnt ligands and
receptors, such as Wnt3, Wnt6, and Fz9 (Zheng et al., 2010).
Thus, FoxM1 behaves similarly to TCF4 and LEF-1, which not
only mediate but also are targets of Wnt signaling, setting up
positive regulatory loops involved in carcinogenesis (MacDonald
et al., 2009).
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Self-Renewal and Glioma Formation
The Wnt signaling pathway is known to be essential for the main-
tenance of tissue-specific stem cells in some organs, including
NSCs (Clevers, 2006; Moon et al., 2004; Nusse, 2008; Zheng
et al., 2010). Accordingly, GICs may possess some properties of
normal NSCs and be responsible for the initiation of glioma (Lee
et al., 2006; Park and Rich, 2009; Singh et al., 2003). We found
that FoxM1 regulates b-catenin activation in both NSCs and
GICs. Moreover, b-catenin activation is required for GIC self-
renewal and tumorigenicity, and FoxM1 plays an essential role
inWnt/b-catenin signaling in themaintenance ofGIC self-renewal
and glioma formation. These results were supported further by
our finding of a strong correlation between elevated nuclear
b-catenin and FoxM1 levels in human primary GBM. The role of
FoxM1 in Wnt/b-catenin signaling is unlikely to be limited to
glioma, because FoxM1 is also essential for intestinal tumorigen-
esis (Yoshida et al., 2007), which has a well-established associa-
tion with overactivation of b-catenin signaling (Clevers, 2006).
In summary, our study has revealed that FoxM1 is a critical
regulator of Wnt/b-catenin signaling and that FoxM1 overex-
pression contributes to the up-regulation of b-catenin signaling
in tumors, such as glioma, in which APC or CTNNB1 mutations
are uncommon. Given the importance of FoxM1 and the Wnt/
b-catenin signaling pathway in human cancers in general, our
findings not only provide an improved understanding of the
molecular mechanisms underlying b-catenin activation and
tumorigenesis but also suggest additional targets for therapeutic
intervention.
EXPERIMENTAL PROCEDURES
Cell Lines and Culture Conditions
The human glioma cell lines (Hs683 and SW1783) and the human embryonic
kidney cell line (293T) were obtained from the American Type Culture Collec-
tion and cultured in DMEM with 10% FBS. The GIC lines were established
by isolating neurosphere-forming cells from surgical specimens of human
GBM using a method described previously (Lee et al., 2006). The study was
approved by the Institutional Review Board of M. D. Anderson Cancer Center,
and informed consent was obtained from all subjects. These GIC lines were
cultured as GBM neurospheres in DMEM/F12medium containing B27 supple-
ment (Invitrogen) and bFGF and EGF (20 ng/ml each).
Time-Lapse Imaging with Confocal Laser-Scanning Microscopes
293T cells were transiently cotransfected with pDsRed-FoxM1 and pCFP-
b-catenin. The localization and intensity of FoxM1 and b-catenin were imaged
with a confocal imaging system (Olympus FluoView FV1000), with the DsRed
and CFP fluorescent proteins activated by laser at 543 and 457 nm, respec-
tively. Fluorescence intensity was quantified with FluoView platform software.
Time-lapse plots of relative nuclear fluorescence intensity were produced from
the cells treated with Wnt3a.
IF Staining and Confocal Microscopy
GICs were grown on chamber slides precoated with poly-L-ornithine and fibro-
nectin. Cells were fixed with 4% paraformaldehyde, permeabilized for 5 min
with PBS containing 0.1% Triton X-100 (PBS-T), quenched with 50 mM
NH4Cl in PBS-T, and blockedwith 1%BSA in PBS-T. Immunostainingwas per-
formed using the appropriate primary and secondary antibodies, and images
were acquired using an Olympus FluoView FV1000 confocal microscope.
Intracranial Tumor Assay
All mouse experiments were approved by the Institutional Animal Care and
Use Committee of M. D. Anderson. Male athymic BALB/c nude mice wereCpurchased from NCI. Glioma cells were injected intracranially into nude mice
as described previously (Liu et al., 2006). Animals were killed when they
were moribund; the remaining animals were killed 120 days after glioma-cell
injection. Each mouse’s brain was harvested, fixed in 4% formaldehyde, and
embedded in paraffin. Tumor formation was determined by histologic analysis
of H&E-stained sections.
Statistical Analysis
We determined the significance of differences in the human GBM data using
Pearson’s correlation test, in the in vitro data using Student’s t test (two-tailed),
and in the in vivo data using theMann-WhitneyU test. p < 0.05 was considered
to be significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and may be found with this
article online at doi:10.1016/j.ccr.2011.08.016.
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